These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8398668)

  • 1. Prevention of recurrent central venous catheter infections with a novel flush solution in a patient on long-term hemodialysis.
    Sheth KJ; Henrickson KJ
    Pediatr Nephrol; 1993 Aug; 7(4):506. PubMed ID: 8398668
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial.
    Henrickson KJ; Axtell RA; Hoover SM; Kuhn SM; Pritchett J; Kehl SC; Klein JP
    J Clin Oncol; 2000 Mar; 18(6):1269-78. PubMed ID: 10715297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: heparin-vancomycin solution to prevent central venous catheter infections.
    Powell KR
    J Pediatr; 1995 Dec; 127(6):1008-9. PubMed ID: 8523176
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients.
    Barriga FJ; Varas M; Potin M; Sapunar F; Rojo H; Martinez A; Capdeville V; Becker A; Vial PA
    Med Pediatr Oncol; 1997 Mar; 28(3):196-200. PubMed ID: 9024516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS; Alex CP; Henrickson KJ; McAuliffe TL; Maki DG
    Pediatrics; 2005 Aug; 116(2):e198-205. PubMed ID: 15995005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children.
    Rackoff WR; Weiman M; Jakobowski D; Hirschl R; Stallings V; Bilodeau J; Danz P; Bell L; Lange B
    J Pediatr; 1995 Jul; 127(1):147-51. PubMed ID: 7608801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia.
    Onder AM; Chandar J; Simon N; Diaz R; Nwobi O; Abitbol CL; Zilleruelo G
    Nephrol Dial Transplant; 2008 Aug; 23(8):2604-10. PubMed ID: 18332071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of bacteremia attributed to luminal colonization of tunneled central venous catheters with vancomycin-susceptible organisms.
    Schwartz C; Henrickson KJ; Roghmann K; Powell K
    J Clin Oncol; 1990 Sep; 8(9):1591-7. PubMed ID: 2202792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter.
    Vercaigne LM; Sitar DS; Penner SB; Bernstein K; Wang GQ; Burczynski FJ
    Pharmacotherapy; 2000 Apr; 20(4):394-9. PubMed ID: 10772369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomized, prospective trial.
    Oguzhan N; Pala C; Sipahioglu MH; Cilan H; Durmaz S; Percin D; Unal A; Tokgoz B; Utas C; Oymak O
    Ren Fail; 2012; 34(2):181-8. PubMed ID: 22260745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of an antibiotic lock for the prevention of bacteremia recurrence from central catheters in chronic hemodialysis].
    Fourcade J; Mallaval FO; Raffenot D; Mercier D; Maret J; Morel B
    Nephrologie; 2001; 22(8):457-8. PubMed ID: 11811009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid versus vancomycin antibiotic lock solution for the prevention of nontunneled catheter-related blood stream infections in hemodialysis patients: a prospective randomized study.
    Sofroniadou S; Revela I; Smirloglou D; Makriniotou I; Zerbala S; Kouloubinis A; Samonis G; Iatrou C
    Semin Dial; 2012 May; 25(3):344-50. PubMed ID: 22074188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifampicin-protamine protocol applied for prevention of central catheter sepsis in haemodialysis.
    Montagnac R; Schillinger F
    Nephrol Dial Transplant; 1993; 8(3):289-90. PubMed ID: 8385301
    [No Abstract]   [Full Text] [Related]  

  • 15. Epicardial cardiac rhythm devices for dialysis patients: minimizing the risk of infection and preserving central veins.
    Asif A; Carrillo R; Garisto JD; Lopera G; Ladino M; Barakat U; Eid N; Salman L
    Semin Dial; 2012; 25(1):88-94. PubMed ID: 20807391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access.
    Bleyer AJ; Mason L; Russell G; Raad II; Sherertz RJ
    Infect Control Hosp Epidemiol; 2005 Jun; 26(6):520-4. PubMed ID: 16018426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transvenous cardiac implantable electronic devices and hemodialysis catheters: recommendations to curtail a potentially lethal combination.
    Asif A; Salman L; Lopera G; Haqqie SS; Carrillo R
    Semin Dial; 2012; 25(5):582-6. PubMed ID: 22353033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of intralumenal and antibiotic-lock of vancomycin on the rate of catheter removal in the patients with permanent hemodialysis catheters.
    Beigi AA; Khansoltani S; Masoudpour H; Atapour AA; Eshaghian A; Khademi EF
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):54-8. PubMed ID: 20061693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic lock technique to reduce central venous catheter-related bacteremia.
    Toltzis P
    Pediatr Infect Dis J; 2006 May; 25(5):449-50. PubMed ID: 16645511
    [No Abstract]   [Full Text] [Related]  

  • 20. Empiric therapy of bacteremia with teicoplanin in hemodialysis patients.
    Brodersen JP; Beckers B; Stolpmann RM; Kohl D; Holtkamp W; Larbig D
    Clin Nephrol; 1995 May; 43(5):347. PubMed ID: 7634554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.